Taking abiraterone PSA is still elevated, first of all, in-depth examination to assess the patient’s condition, due to the disease progression caused by the elevation of indicators, you can choose to switch to other anti-tumor treatment, if it is due to insufficient time for treatment caused by the elevation of PSA, you can continue to take abiraterone treatment. Patients first need to do ultrasound, magnetic resonance, abdominal CT and other imaging examinations of the prostate to assess the progression of prostate cancer 1. If the imaging test indicates that the prostate cancer has progressed, abiraterone is not effective, and then the patient should consider switching to systemic chemotherapy or other endocrine drugs for treatment. 2. If there is no sign of prostate cancer progression in the imaging test, consider that the increase in PSA is due to insufficient treatment time of abiraterone and transient increase in PSA caused by the use of the drug, then you can continue to take abiraterone to control the progression of prostate cancer. Please strictly follow the doctor’s instructions for drug treatment and do not use drugs on your own.